Aclaris Therapeutics, Inc. (ACRS)
4.43
+1.81
(+69.08%)
USD |
NASDAQ |
Jan 20, 16:00
4.38
-0.05
(-1.13%)
After-Hours: 20:00
Aclaris Therapeutics EPS Diluted (Quarterly): -0.1192 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Puma Biotechnology, Inc. | 0.1736 |
| Nephros, Inc. | 0.0305 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Vivos Therapeutics, Inc. | -0.4925 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.61M |
| Revenue (Quarterly) | 3.299M |
| Total Expenses (Quarterly) | 17.91M |
| Enterprise Value | 386.30M |
| Gross Profit Margin (Quarterly) | 25.77% |
| Profit Margin (Quarterly) | -443.0% |
| Earnings Yield | -31.18% |
| Normalized Earnings Yield | -16.72 |